Sabrina Lusvarghi

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies

Sabrina Lusvarghi, Simon Pollett, Sabari Nath Neerukonda et al. · Science Translational Medicine · 2022 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability

Rosemarie D. Mason, Hugh C. Welles, Cameron Adams et al. · PLoS Pathogens · 2016 · 77 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines

Chung‐Pu Wu, Sabrina Lusvarghi, Jyun-Cheng Wang et al. · Molecular Pharmaceutics · 2019 · 74 citations · Full text

Medicine, Oncology, Pharmacology +16

Synthesis, stereoelectronic characterization and antiparasitic activity of new 1-benzenesulfonyl-2-methyl-1,2,3,4-tetrahydroquinolines

Romina J. Pagliero, Sabrina Lusvarghi, Adriana B. Pierini et al. · Bioorganic & Medicinal Chemistry · 2009 · 72 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +13

Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history

Wei Wang, Sabrina Lusvarghi, Rahul Subramanian et al. · Cell Host & Microbe · 2022 · 72 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15